Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10665063 [patent_doc_number] => 20160011207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATION-INDUCED DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/648802 [patent_app_country] => US [patent_app_date] => 2013-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17646 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648802 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/648802
DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATION-INDUCED DISORDERS Dec 4, 2013 Abandoned
Array ( [id] => 12172067 [patent_doc_number] => 09890194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-13 [patent_title] => 'Epitope and its use' [patent_app_type] => utility [patent_app_number] => 14/441248 [patent_app_country] => US [patent_app_date] => 2013-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 3684 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14441248 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/441248
Epitope and its use Nov 6, 2013 Issued
Array ( [id] => 10406663 [patent_doc_number] => 20150291672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'Contact Lens Surface Modification with Hyaluronic Acid (HA) Binding Peptide for HA Accumulation and Retention' [patent_app_type] => utility [patent_app_number] => 14/439270 [patent_app_country] => US [patent_app_date] => 2013-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 3501 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439270 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/439270
Contact Lens Surface Modification with Hyaluronic Acid (HA) Binding Peptide for HA Accumulation and Retention Oct 31, 2013 Abandoned
Array ( [id] => 10362134 [patent_doc_number] => 20150247139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS' [patent_app_type] => utility [patent_app_number] => 14/427234 [patent_app_country] => US [patent_app_date] => 2013-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10830 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427234 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/427234
Recombinant clostridium botulinum neurotoxins Oct 30, 2013 Issued
Array ( [id] => 11318161 [patent_doc_number] => 09516893 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-13 [patent_title] => 'Use of tryptophan rich protein hydrolysates' [patent_app_type] => utility [patent_app_number] => 14/404878 [patent_app_country] => US [patent_app_date] => 2013-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14490 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404878 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/404878
Use of tryptophan rich protein hydrolysates Oct 29, 2013 Issued
Array ( [id] => 9477293 [patent_doc_number] => 20140134756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'BIOMOLECULAR RECOGNITION OF CRYSTAL DEFECTS' [patent_app_type] => utility [patent_app_number] => 14/059639 [patent_app_country] => US [patent_app_date] => 2013-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9658 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059639 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/059639
BIOMOLECULAR RECOGNITION OF CRYSTAL DEFECTS Oct 21, 2013 Abandoned
Array ( [id] => 10470163 [patent_doc_number] => 20150355179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'CDKACT BIOSENSORS-FLUORESCENT POLYPEPTIDE TO PROBE THE ACTIVITY OF CDK/CYCLIN KINASES IN VITRO, IN CELLULO AND IN VIVO' [patent_app_type] => utility [patent_app_number] => 14/433934 [patent_app_country] => US [patent_app_date] => 2013-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14153 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433934 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/433934
CDKACT BIOSENSORS-FLUORESCENT POLYPEPTIDE TO PROBE THE ACTIVITY OF CDK/CYCLIN KINASES IN VITRO, IN CELLULO AND IN VIVO Oct 9, 2013 Abandoned
Array ( [id] => 9363155 [patent_doc_number] => 20140073028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'MEK Ligands and Polynucleotides Encoding MEK Ligands' [patent_app_type] => utility [patent_app_number] => 14/046454 [patent_app_country] => US [patent_app_date] => 2013-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 10159 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046454 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/046454
MEK ligands and polynucleotides encoding MEK ligands Oct 3, 2013 Issued
Array ( [id] => 9685876 [patent_doc_number] => 20140242640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'Methods of Making Nanotechnological and Macromolecular Biomimetic Structures' [patent_app_type] => utility [patent_app_number] => 14/039717 [patent_app_country] => US [patent_app_date] => 2013-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19425 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14039717 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/039717
Methods of Making Nanotechnological and Macromolecular Biomimetic Structures Sep 26, 2013 Abandoned
Array ( [id] => 11915407 [patent_doc_number] => 09783585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-10 [patent_title] => 'Compositions and methods for increasing the expression and signalling of proteins on cell surfaces' [patent_app_type] => utility [patent_app_number] => 14/427090 [patent_app_country] => US [patent_app_date] => 2013-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 13036 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427090 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/427090
Compositions and methods for increasing the expression and signalling of proteins on cell surfaces Sep 25, 2013 Issued
Array ( [id] => 11389575 [patent_doc_number] => 09550809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-24 [patent_title] => 'High affinity metal-oxide binding peptides with reversible binding' [patent_app_type] => utility [patent_app_number] => 14/034420 [patent_app_country] => US [patent_app_date] => 2013-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 22 [patent_no_of_words] => 15248 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14034420 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/034420
High affinity metal-oxide binding peptides with reversible binding Sep 22, 2013 Issued
Array ( [id] => 12037648 [patent_doc_number] => 09815867 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-14 [patent_title] => 'Peptide for inhibiting vascular endothelial growth factor receptor' [patent_app_type] => utility [patent_app_number] => 14/424192 [patent_app_country] => US [patent_app_date] => 2013-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 13405 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424192 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/424192
Peptide for inhibiting vascular endothelial growth factor receptor Sep 1, 2013 Issued
Array ( [id] => 10142462 [patent_doc_number] => 09175263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Methods and compositions for targeting progenitor cell lines' [patent_app_type] => utility [patent_app_number] => 13/972695 [patent_app_country] => US [patent_app_date] => 2013-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 19 [patent_no_of_words] => 25086 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13972695 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/972695
Methods and compositions for targeting progenitor cell lines Aug 20, 2013 Issued
Array ( [id] => 9319319 [patent_doc_number] => 20140051657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'METHODS AND SYSTEMS FOR SCREENING COMPOSITIONS COMPRISING NON-ANTICOAGULANT SULFATED POLYSACCHARIDES' [patent_app_type] => utility [patent_app_number] => 13/964684 [patent_app_country] => US [patent_app_date] => 2013-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 33343 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13964684 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/964684
Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides Aug 11, 2013 Issued
Array ( [id] => 11303705 [patent_doc_number] => 09511087 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-06 [patent_title] => 'Use of antithrombin in extracorporeal membrane oxygenation' [patent_app_type] => utility [patent_app_number] => 14/239943 [patent_app_country] => US [patent_app_date] => 2013-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6502 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239943 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/239943
Use of antithrombin in extracorporeal membrane oxygenation Aug 1, 2013 Issued
Array ( [id] => 12445473 [patent_doc_number] => 09981004 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-29 [patent_title] => Inhibition of TREM receptor signaling with peptide variants [patent_app_type] => utility [patent_app_number] => 13/941445 [patent_app_country] => US [patent_app_date] => 2013-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23858 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941445 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/941445
Inhibition of TREM receptor signaling with peptide variants Jul 11, 2013 Issued
Array ( [id] => 11535931 [patent_doc_number] => 09610324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-04 [patent_title] => 'Apolipoprotein mixtures' [patent_app_type] => utility [patent_app_number] => 14/413918 [patent_app_country] => US [patent_app_date] => 2013-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 27 [patent_no_of_words] => 32444 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413918 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/413918
Apolipoprotein mixtures Jul 10, 2013 Issued
Array ( [id] => 10103870 [patent_doc_number] => 09139645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Peptides and related molecules that bind to TALL-1' [patent_app_type] => utility [patent_app_number] => 13/938141 [patent_app_country] => US [patent_app_date] => 2013-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 40 [patent_no_of_words] => 23348 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13938141 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/938141
Peptides and related molecules that bind to TALL-1 Jul 8, 2013 Issued
Array ( [id] => 10290663 [patent_doc_number] => 20150175662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'NOVEL PEPTIDES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/412020 [patent_app_country] => US [patent_app_date] => 2013-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8973 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412020 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/412020
Peptides and use thereof Jul 2, 2013 Issued
Array ( [id] => 11697662 [patent_doc_number] => 09687560 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-27 [patent_title] => 'Skin-permeating peptide' [patent_app_type] => utility [patent_app_number] => 14/404928 [patent_app_country] => US [patent_app_date] => 2013-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5719 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404928 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/404928
Skin-permeating peptide May 30, 2013 Issued
Menu